MedTrace Logo

Contingency Management for Drug Use: Does Age Matter?

NCT05521854 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 175

Last updated 2026-03-17

No results posted yet for this study

Summary

The OVERALL AIM is to assess whether app-based incentives are effective for older adults and to quantify the associations between age and both the efficacy and take-up of app-based incentives. This will allow us to determine if older adults with substance use disorders (SUDs) are willing to engage with app-based incentives and whether they perform similarly to their younger counterparts. Because the study will leverage data from an existing study on app-based incentives, a small add-on study is sufficient to address these three aims. This aim will be achieved while simultaneously gathering data that will shed light on the two aims of the first phase of the study: whether app-based incentives are effective overall, and how to optimize the size of incentives over time to maximize their effectiveness.

Conditions

Interventions

BEHAVIORAL

DynamiCare app (app-based contingency management)

Participants will receive financial incentives for submitting randomly generated drug-negative saliva tests across the intervention period.

BEHAVIORAL

Sham control

Participants get access to the DynamiCare app but will not be provided with financial incentives.

Sponsors & Collaborators

Principal Investigators

  • Mercedes Robaina · Wake Forest University Health Sciences

  • Ariel Zucher, PhD · University of California Santa Cruz

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2026-05-31
Completion
2026-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05521854 on ClinicalTrials.gov